The Patent Finder
US

Factor IX Polypeptides and Methods of Use Thereof

US 9,670,475 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jul 11, 2031 · Medium confidence

Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 9,233,145), so the cap could be lower.

Filed Apr 24, 2013 as application 13/809,276 · Granted Jun 6, 2017
Base term plus 495 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2011 2031
Clock starts
Jul 11, 2011
Term ends
Jul 11, 2031
Granted
Jun 6, 2017
base term fee events Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
495
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 9,233,145, US 9,623,091, US 9,629,903, US 9,675,676, US 9,867,873.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
14
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 495 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jul 11, 2011, when application PCT/US2011/043569, the earliest non-provisional in its chain, was filed (this one was filed Apr 24, 2013)Jul 11, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+495 days, USPTO patent term adjustment recordNov 17, 2032High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 9,233,145, US 9,623,091, US 9,629,903, US 9,675,676, US 9,867,873)capped to Jul 11, 2031Medium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJul 11, 2031Medium confidence

This family

Application PCT/US2011/043569PCT application
no patent term
no patent term
US 9,233,145In force
no later than Sep 2031
no later than Sep 2031
US 9,670,475this patent
Jul 2031
Jul 2031
US 9,867,873In force
Jul 2031
Jul 2031
US 9,675,676In force
Jul 2031
Jul 2031
US 9,623,091In force
Jul 2031
Jul 2031
US 9,629,903In force
Jul 2031
Jul 2031
Application 15/820,080Abandoned
not computed
not computed
8 of 14 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 10, 2013
Reel 30389, frame 721
Pierce, Glenn; Truex, Samantha; Peters, Robert T.; Jiang, HaiyanBiogen Idec Hemophilia Inc.Assignment of Assignor's Interest
Apr 30, 2015
Reel 35553, frame 325
Biogen Idec Hemophilia Inc.Biogen Hemophilia Inc.Change of Name
Jul 2, 2015
Reel 36051, frame 773
Biogen Hemophilia Inc.Biogen Hemophilia Inc.Change of Address
Feb 16, 2017
Reel 41735, frame 703
Biogen Hemophilia Inc.Bioverativ Therapeutics Inc.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited